Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Ratios

Tectonic Therapeutic (TECX) Amortization of Deferred Charges (2017 - 2018)

Tectonic Therapeutic (TECX) has 2 years of Amortization of Deferred Charges data on record, last reported at $4000.0 in Q4 2018.

On a quarterly basis, Amortization of Deferred Charges fell 63.64% to $4000.0 in Q4 2018 year-over-year; TTM through Dec 2018 was $37000.0, a N/A change, with the full-year FY2018 number at $37000.0, up 54.17% from a year prior.
Amortization of Deferred Charges reached $4000.0 in Q4 2018 per TECX's latest filing, down from $11000.0 in the prior quarter.
Over the last five years, Amortization of Deferred Charges for TECX hit a ceiling of $11000.0 in Q3 2017 and a floor of $4000.0 in Q4 2018.